scispace - formally typeset
Journal ArticleDOI

A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists.

Reads0
Chats0
TLDR
Two different approaches used successfully with other peptides in an attempt to identify new VIP receptor antagonists are adopted, one involving the formation of pseudopeptides by insertion of reduced peptide bonds in the NH2-terminus from position 2 to 8 of VIP and the other by combining VIP(6-28) and PACAP(28-38).
About
This article is published in Peptides.The article was published on 1994-01-01. It has received 60 citations till now.

read more

Citations
More filters
Journal ArticleDOI

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

TL;DR: The described molecule in the first reported VIP antagonist with an affinity in the nM range and with a high selectivity for the VIP1 receptor subclass may be useful for evaluation of the physiological role of VIP in rat and human tissues.
Journal ArticleDOI

VIP as a trophic factor in the CNS and cancer cells

TL;DR: VIP is an integrative regulator of brain growth and development during neurogenesis and embryogenesis and potentiates the ability of chemotherapeutic drugs to kill cancer cells.
Journal ArticleDOI

The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy

TL;DR: Analysis of the expression and influence of VPAC1, VPAC2 and PAC1 receptors in rat spinal dorsal horn following a chronic constriction injury indicates that VIP/PACAP receptors may be important regulatory factors in neuropathic pain states.
Journal ArticleDOI

Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC2 receptor

TL;DR: This molecule represents the first selective human VPAC(2) receptor antagonist described to date and is developed as a VIP or Ro 25-1553 analog behaving as a high affinity, VPAC (2) selective antagonist.
References
More filters
Journal ArticleDOI

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

TL;DR: The analysis described shows K I does not equal I 50 when competitive inhibition kinetics apply; however, K I is equal to I 50 under conditions of either noncompetitive or uncompetitive kinetics.
Journal ArticleDOI

Handbook of Physiology.

Fred Plum
- 01 Mar 1960 - 
TL;DR: This is the first volume of the proposed many-sectioned "Handbook" in which the American Physiological Society intends to present comprehensively the entire field of physiology.
Book

Physiology of the Gastrointestinal Tract

TL;DR: Physiology of the Gastrointestinal Tract, Fifth Edition - winner of a 2013 Highly Commended BMA Medical Book Award for Internal Medicine - covers the study of the mechanical, physical, and biochemical functions of the GI Tract while linking the clinical disease or disorder, bridging the gap between clinical and laboratory medicine.
Journal ArticleDOI

Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37).

TL;DR: Human calcitonin gene-related peptide fragment hCGRP-(8-37) appears to be a useful tool for determining whether the action of CGRP as well as that of CT is mediated via specific C GRP receptors or CT receptors.
PatentDOI

Vasoactive intestinal peptide

TL;DR: In this article, biological actions including systemic vasodilation, hypotension, increased cardiac output, respiratory stimulation, and hyperglycemia were isolated from intestines of animals such as a hog.
Related Papers (5)